A mission GN Corporation started in 2008 to address ocular surface (corneal epithelium) diseases through buccal mucosal cell therapy took a diversification and yielded a successful result in solving male urethral stricture. The clinical results published in 2018, attracted the attention of the Urologists in Japan, jointly with them pre-clinical studies have been started.
The basic data of in vitro cell culture, an outcome of 13-year research got published in April 2021.
Please click here to see the paper in The Tokai Journal of Experimental and Clinical Medicine.
